Literature DB >> 9613605

Cross-linking and mutational analysis of the oligomerization state of the cytokine macrophage migration inhibitory factor (MIF).

R Mischke1, R Kleemann, H Brunner, J Bernhagen.   

Abstract

The structure of the cytokine MIF has been investigated by X-ray crystallography, NMR, and biochemical methods with conflicting results regarding the structural and functional oligomerization state of this protein. Determination of the oligomeric state(s) is important for understanding more precisely the molecular mechanism of MIF action. To address this issue, we performed cross-linking of human and mouse MIF and selected mutants by various methods and analyzed the oligomerization by SDS-PAGE and gel filtration. MIF was found to form a mixture of monomeric, dimeric, and trimeric states at physiological concentrations, with the monomer and dimer representing the major species. Similar results were obtained when the carboxy-truncated mutants MIF(1-104) and MIF(1-109) were examined, indicating that the C-terminus of MIF is not critical for trimer stabilization. Cross-linking analysis of the isosteric Cys --> Ser mutants C56S and C80S of human MIF resulted in a similar oligomer distribution, whereas substitution of Cys59 led to a significant reduction in the dimeric and trimeric forms, indicating that the hydrophobic region around Cys59 is important for the oligomerization of MIF. Together, our data argue that physiological MIF solutions contain a mixture of monomers, dimers, and trimers.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9613605     DOI: 10.1016/s0014-5793(98)00400-1

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  20 in total

1.  Characterization of Neospora caninum macrophage migration inhibitory factor.

Authors:  Guanggang Qu; Raymond Fetterer; Mark Jenkins; Lin Leng; Zhiqiang Shen; Charles Murphy; Wenyu Han; Richard Bucala; Wenbin Tuo
Journal:  Exp Parasitol       Date:  2013-07-11       Impact factor: 2.011

2.  MIF as a biomarker and therapeutic target for overcoming resistance to proteasome inhibitors in human myeloma.

Authors:  Qiang Wang; Dongyu Zhao; Miao Xian; Zhuo Wang; Enguang Bi; Pan Su; Jianfei Qian; Xingzhe Ma; Maojie Yang; Lintao Liu; Youli Zu; Sai Ravi Pingali; Kaifu Chen; Zhen Cai; Qing Yi
Journal:  Blood       Date:  2020-11-26       Impact factor: 22.113

3.  Macrophage migration inhibitory factor as a chaperone inhibiting accumulation of misfolded SOD1.

Authors:  Adrian Israelson; Dara Ditsworth; Shuying Sun; SungWon Song; Jason Liang; Marian Hruska-Plochan; Melissa McAlonis-Downes; Salah Abu-Hamad; Guy Zoltsman; Tom Shani; Marcus Maldonado; Anh Bui; Michael Navarro; Huilin Zhou; Martin Marsala; Brian K Kaspar; Sandrine Da Cruz; Don W Cleveland
Journal:  Neuron       Date:  2015-03-19       Impact factor: 17.173

4.  Ostertagia ostertagi macrophage migration inhibitory factor is present in all developmental stages and may cross-regulate host functions through interaction with the host receptor.

Authors:  Guanggang Qu; Raymond Fetterer; Lin Leng; Xin Du; Dante Zarlenga; Zhiqiang Shen; Wenyu Han; Richard Bucala; Wenbin Tuo
Journal:  Int J Parasitol       Date:  2014-02-28       Impact factor: 3.981

5.  MIF intersubunit disulfide mutant antagonist supports activation of CD74 by endogenous MIF trimer at physiologic concentrations.

Authors:  Chengpeng Fan; Deepa Rajasekaran; Mansoor Ali Syed; Lin Leng; J Patrick Loria; Vineet Bhandari; Richard Bucala; Elias J Lolis
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-17       Impact factor: 11.205

6.  Macrophage migration inhibitory factor: identification of the 30-kDa MIF-related protein in bovine brain.

Authors:  O A Cherepkova; B Ya Gurvits
Journal:  Neurochem Res       Date:  2004-07       Impact factor: 3.996

7.  Functional characterization of the Plasmodium falciparum and P. berghei homologues of macrophage migration inhibitory factor.

Authors:  Kevin D Augustijn; Robert Kleemann; Joanne Thompson; Teake Kooistra; Carina E Crawford; Sarah E Reece; Arnab Pain; Arjan H G Siebum; Chris J Janse; Andrew P Waters
Journal:  Infect Immun       Date:  2006-12-11       Impact factor: 3.441

8.  Characterization of molecular determinants of the conformational stability of macrophage migration inhibitory factor: leucine 46 hydrophobic pocket.

Authors:  Farah El-Turk; Bruno Fauvet; Amer Ashrafi; Hajer Ouertatani-Sakouhi; Min-Kyu Cho; Marilisa Neri; Michele Cascella; Ursula Rothlisberger; Florence Pojer; Markus Zweckstetter; Hilal Lashuel
Journal:  PLoS One       Date:  2012-09-21       Impact factor: 3.240

9.  The crystal structures of macrophage migration inhibitory factor from Plasmodium falciparum and Plasmodium berghei.

Authors:  Sarah E Dobson; Kevin D Augustijn; James A Brannigan; Claudia Schnick; Chris J Janse; Eleanor J Dodson; Andrew P Waters; Anthony J Wilkinson
Journal:  Protein Sci       Date:  2009-12       Impact factor: 6.725

10.  Arrest Functions of the MIF Ligand/Receptor Axes in Atherogenesis.

Authors:  Sabine Tillmann; Jürgen Bernhagen; Heidi Noels
Journal:  Front Immunol       Date:  2013-05-16       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.